Terms: = Breast cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Prognosis
8 results:
1. Long-term prognostic effect of hormone receptor subtype on breast cancer.
Hwang KT; Kim J; Jung J; Kim BH; Park JH; Jeon SY; Hwang KR; Roh EY; Park JH; Kim SJ
Breast Cancer Res Treat; 2020 Jan; 179(1):139-151. PubMed ID: 31595365
[TBL] [Abstract] [Full Text] [Related]
2. Promyelocytic leukemia protein (pml) controls breast cancer cell proliferation by modulating Forkhead transcription factors.
Sachini N; Arampatzi P; Klonizakis A; Nikolaou C; Makatounakis T; Lam EW; Kretsovali A; Papamatheakis J
Mol Oncol; 2019 Jun; 13(6):1369-1387. PubMed ID: 30927552
[TBL] [Abstract] [Full Text] [Related]
3. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract] [Full Text] [Related]
4. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract] [Full Text] [Related]
5. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract] [Full Text] [Related]
6. Barnacle: detecting and characterizing tandem duplications and fusions in transcriptome assemblies.
Swanson L; Robertson G; Mungall KL; Butterfield YS; Chiu R; Corbett RD; Docking TR; Hogge D; Jackman SD; Moore RA; Mungall AJ; Nip KM; Parker JD; Qian JQ; Raymond A; Sung S; Tam A; Thiessen N; Varhol R; Wang S; Yorukoglu D; Zhao Y; Hoodless PA; Sahinalp SC; Karsan A; Birol I
BMC Genomics; 2013 Aug; 14():550. PubMed ID: 23941359
[TBL] [Abstract] [Full Text] [Related]
7. A metabolic prosurvival role for pml in breast cancer.
Carracedo A; Weiss D; Leliaert AK; Bhasin M; de Boer VC; Laurent G; Adams AC; Sundvall M; Song SJ; Ito K; Finley LS; Egia A; Libermann T; Gerhart-Hines Z; Puigserver P; Haigis MC; Maratos-Flier E; Richardson AL; Schafer ZT; Pandolfi PP
J Clin Invest; 2012 Sep; 122(9):3088-100. PubMed ID: 22886304
[TBL] [Abstract] [Full Text] [Related]
8. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.
Subhawong AP; Heaphy CM; Argani P; Konishi Y; Kouprina N; Nassar H; Vang R; Meeker AK
Mod Pathol; 2009 Nov; 22(11):1423-31. PubMed ID: 19734843
[TBL] [Abstract] [Full Text] [Related]
